Skip to main content
An official website of the United States government
Español
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

toripalimab

(TOR-ih-PA-lih-mab)
A drug used alone or with other drugs to treat adults with certain types of nasopharyngeal cancer (a type of head and neck cancer). It is also being studied in the treatment of other types of cancer. Toripalimab binds to a protein called PD-1, which is found on T cells (a type of immune cell). Blocking this protein may help the immune system kill cancer cells. Toripalimab is a type of monoclonal antibody and a type of immune checkpoint inhibitor. Also called Loqtorzi.
More Information
Search NCI's Dictionary of Cancer Terms